Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CLDI
CLDI logo

CLDI Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Calidi Biotherapeutics Inc (CLDI) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Sell
Latest Price
0.210
1 Day change
-2.77%
52 Week Range
19.200
Analysis Updated At
2026/05/08
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

CLDI is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock is trading weakly below the previous close, the broader trend remains bearish, there are no recent bullish news or insider/hedge fund signals, and the company is still reporting losses with no revenue growth. With no AI Stock Picker or SwingMax signal and no clear catalyst, this is not an attractive entry today.

Technical Analysis

The technical setup is weak. Price is 0.2077, below the previous close of 0.2165, with pre-market, regular session, and post-market pressure all negative. RSI_6 at 42.8 is neutral, so momentum is not oversold enough to suggest a strong rebound. MACD histogram is positive but contracting, which suggests fading short-term momentum rather than a strong breakout. The moving averages are bearish with SMA_200 > SMA_20 > SMA_5, confirming a downtrend. Support sits near 0.198 and 0.18, while resistance is 0.226 and 0.255. The stock trend model also points to soft expected performance over the next week and month.

Positive Catalysts

  • No recent news in the past week. No AI Stock Picker signal today. No SwingMax signal recently. Hedge funds and insiders are neutral, so there is no meaningful accumulation signal. If the stock holds above 0.198 support, a short-term technical bounce could occur, but there is no strong catalyst backing it.

Neutral/Negative Catalysts

  • No recent news flow, no positive options sentiment, no strong proprietary trading signal, and no notable insider or hedge fund buying. The market trend is bearish, and the stock is showing continued weakness in both pre-market and post-market activity. The company’s earnings remain deeply negative, and EPS deteriorated sharply year over year.

Financial Performance

Latest reported quarter: 2025/Q4. Revenue was 0, showing no sales growth. Net income was -4,056,000, still negative and slightly worse year over year. EPS was -0.57, down 82.3% YoY, indicating material deterioration in per-share profitability. Gross margin was 0, which reflects no operating revenue base supporting the business.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so there is no recent Wall Street upgrade/downgrade trend to report. Based on the available fundamentals and technicals, the Wall Street pros view would likely lean cautious-to-bearish: the business is loss-making with no revenue growth, while the stock trend remains weak and lacks near-term catalysts.

Wall Street analysts forecast CLDI stock price to rise
Analyst Rating
0
Wall Street analysts forecast CLDI stock price to rise
Buy
Hold
Sell
0
Current: 0.216
sliders
Low
0
Averages
0
High
0
0
Current: 0.216
sliders
Low
0
Averages
0
High
0
No data

No data

People Also Watch